Cinemark price target raised to $36 from $35 at Roth Capital

Roth Capital raised the firm’s price target on Cinemark (CNK) to $36 from $35 and keeps a Buy rating on the shares. Following better than expected Q4 results, Cinemark remains in a good position to benefit from an improved movie slate in 2026 and 2027, the analyst tells investors in a research note. Box office growth should fuel margin expansion, higher free cash flow, and increased capital returns, the firm adds.